Advertisement
Screener

BECTON, DICKINSON AND COMPANY (BDX) Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax

2.8 / 5 stars · 68/120 Roast Me

BECTON, DICKINSON AND COMPANY Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax

BECTON, DICKINSON AND COMPANY (BDX) reported Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax of $59.00 million for the 3-month period ending 2018-12-31, per its 10-Q filed 2019-02-05.

Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments

us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax · last filed 2019-02-05

  • BECTON, DICKINSON AND COMPANY gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2018-12-31 was $59.00M.
  • BECTON, DICKINSON AND COMPANY gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2018-09-30 was $134.00M.
  • BECTON, DICKINSON AND COMPANY gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2018-06-30 was $51.00M.
  • BECTON, DICKINSON AND COMPANY gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2018-03-31 was -$103.00M.
  • BECTON, DICKINSON AND COMPANY gain (loss) on derivative used in net investment hedge, after tax for fiscal 2018 was $81.00M.
  • BECTON, DICKINSON AND COMPANY gain (loss) on derivative used in net investment hedge, after tax for fiscal 2017 was -$159.00M.
Period endGain (Loss) on Derivative Used in Net Investment Hedge, after Tax 3 monthGain (Loss) on Derivative Used in Net Investment Hedge, after Tax 6 monthGain (Loss) on Derivative Used in Net Investment Hedge, after Tax 9 monthGain (Loss) on Derivative Used in Net Investment Hedge, after Tax 12 month
2018-12-31$59.00M
10-Q · filed 2019-02-05
$193.00M
derived: sum of 2 quarters · filed 2019-02-05
$244.00M
derived: sum of 3 quarters · filed 2019-02-05
$141.00M
derived: sum of 4 quarters · filed 2019-02-05
2018-09-30$134.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-21
$185.00M
derived: sum of 2 quarters · filed 2018-11-21
$82.00M
derived: sum of 3 quarters · filed 2018-11-21
$81.00M
10-K · filed 2018-11-21
2018-06-30$51.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02
-$52.00M
derived: sum of 2 quarters · filed 2018-08-02
-$53.00M
10-Q · filed 2018-08-02
-$155.00M
derived: sum of 4 quarters · filed 2019-02-05
2018-03-31-$103.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-03
-$104.00M
10-Q · filed 2018-05-03
-$206.00M
derived: sum of 3 quarters · filed 2019-02-05
-$244.00M
derived: sum of 4 quarters · filed 2019-02-05
2017-12-31-$1.00M
10-Q · filed 2019-02-05
-$103.00M
derived: sum of 2 quarters · filed 2019-02-05
-$141.00M
derived: sum of 3 quarters · filed 2019-02-05
-$183.00M
derived: sum of 4 quarters · filed 2019-02-05
2017-09-30-$102.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-21
-$140.00M
derived: sum of 2 quarters · filed 2018-11-21
-$182.00M
derived: sum of 3 quarters · filed 2018-11-21
-$159.00M
10-K · filed 2018-11-21
2017-06-30-$38.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03
-$80.00M
derived: sum of 2 quarters · filed 2017-08-03
-$57.00M
10-Q · filed 2017-08-03
2017-03-31-$42.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-02
-$19.00M
10-Q · filed 2017-05-02
2016-12-31$23.00M
10-Q · filed 2017-02-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
BOSTON SCIENTIFIC CORP (BSX)United States$64.781B17.29
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
3M CO (MMM)United States$86.404B27.87
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73